(Q44115706)

29 November 2017

1 reference

title

Common variable immunodeficiency: 17 observations in the adult (English)

1 reference

reason for deprecated rank

29 November 2017

Le déficit immunitaire commun variable de l’adulte : étude clinique, biologique et immunologique chez 17 patients (French)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(03)00189-9

common variable immunodeficiency

20 March 2024

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(03)00189-9

20 March 2024

author name string

J-F Viallard

2

1 reference

29 November 2017

J-F Moreau

6

1 reference

29 November 2017

J-L Pellegrin

10

1 reference

29 November 2017

C. Bloch-Michel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

P. Blanco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

F. Liferman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

D. Neau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

L. Baillet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

G. Etienne

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

M. Longy-Boursier

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550517

20 March 2024

language of work or name

French

0 references

publication date

1 October 2003

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:S0248866303001899?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(03)00189-9

https://api.elsevier.com/content/article/PII:S0248866303001899?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(03)00189-9

Revue de Médecine Interne

20 March 2024

published in

1 reference

29 November 2017

24

1 reference

29 November 2017

10

1 reference

29 November 2017

640-650

1 reference

Common variable immunodeficiency: how many diseases?

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Common variable immunodeficiency: clinical and immunological features of 248 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Increases in CD3+CD4-CD8- T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Hypergammaglobulinaemia and IgG subclass deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

X-linked lymphoproliferative disease: a progressive immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Pulmonary abnormalities in patients with primary hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Mycoplasma felis septic arthritis in a patient with hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Encephalomyelitis in primary hypogammaglobulinaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

1 reference

7 January 2021

[Common variable immunodeficiency and total villous atrophy regressive after gluten-free diet]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Gastric pathology in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Long-term interferon alpha maintenance therapy for chronic hepatitis C infection in a patient with common variable immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Autoimmunity in human primary immunodeficiency diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Granulomatous disease in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Granulomatous disease in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Interleukin-10 for common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Respiratory disorders in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Study of the B cell memory compartment in common variable immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900189-9

7 January 2021

Identifiers

1 reference

29 November 2017

1 reference